GLP-1 Microdosing Chart & Schedule According to a 2,700-person real-world study presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide: Microdosing GLP-1 Weight Loss Results Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans
Any glucose that does enter the alpha cell is assumed to be metabolised (via glucokinase, glycolysis and the Krebs cycle) to produce ATP, which interacts with ATP-sensitive potassium channels (K ATP channels), leading to cell depolarisation and generation of action potentials [32, 33]
Xiong-Li Yang for his generous support of this project
By activating GLP-1 receptors, retatrutide promotes insulin secretion, suppresses glucagon release, and reduces appetite
This process produces ketonesacidic chemicals that build up in the blood and can become toxic